Hydromorphone Hydrochloride
Product Images NDC 17478-540

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Hydromorphone Hydrochloride (NDC 17478-540). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hyd07 0009 01

Chemical structure diagram of Hydromorphone Hydrochloride showing the molecular arrangement of atoms and bonds for the active ingredient Hydromorphone along with its hydrochloride component.*

FDA Label Image

Hyd07 0009 02

Label for Hydromorphone Hydrochloride Injection, USP high potency formulation by Akorn. It is a sterile 5 mL ampule containing 50 mg per 5 mL (10 mg/mL). The label states it is for prescription use only and intended for use in preparing large volume parenteral solutions. The product NDC is 17478-540-05.*

FDA Label Image

Hyd07 0009 03

Packaging label for Hydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL) in a high potency formulation. The label states it is for use in the preparation of large-volume parenteral solutions and contains 10 ampules of 5 mL each. The labeler is Akorn and the NDC is 17478-540-05. It includes a controlled substance symbol (Schedule II) and indicates the product is sterile.*

FDA Label Image

Hyd07 0009 04

Label for Hydromorphone Hydrochloride Injection, USP 500 mg/50 mL (10 mg/mL) provided by Akorn. The label indicates a high potency formulation in a 50 mL single-dose vial. It includes active and inactive ingredients, dosage note, storage instructions, and manufacturer details. The label also features a barcode and spaces for lot and expiration information.*

FDA Label Image

Hyd07 0009 05

Carton label for Hydromorphone Hydrochloride Injection, USP by Akorn. The label indicates a 50 mL single-dose vial containing 500 mg/50 mL (10 mg/mL). It includes indications of high potency formulation, sterile contents, usage for preparation of large volume parenteral solutions, storage instructions, and a barcode. The label also lists inactive ingredients and manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.